AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
41.42
+0.90 (2.22%)
At close: Jan 6, 2026, 4:00 PM EST
41.44
+0.02 (0.05%)
After-hours: Jan 6, 2026, 4:10 PM EST
AtriCure Market Cap
AtriCure has a market cap or net worth of $2.06 billion as of January 6, 2026. Its market cap has increased by 34.16% in one year.
Market Cap
2.06B
Enterprise Value
1.99B
1-Year Change
34.16%
Ranking
Category
Stock Price
$41.42
Market Cap Chart
Since August 5, 2005, AtriCure's market cap has increased from $167.60M to $2.06B, an increase of 1,129.28%. That is a compound annual growth rate of 13.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 2.01B | 2.43% |
| Dec 31, 2025 | 1.97B | 32.01% |
| Dec 31, 2024 | 1.49B | -11.92% |
| Dec 29, 2023 | 1.69B | -18.05% |
| Dec 30, 2022 | 2.06B | -35.37% |
| Dec 31, 2021 | 3.19B | 27.42% |
| Dec 31, 2020 | 2.51B | 94.93% |
| Dec 31, 2019 | 1.29B | 9.07% |
| Dec 31, 2018 | 1.18B | 87.48% |
| Dec 29, 2017 | 628.80M | -3.34% |
| Dec 30, 2016 | 650.50M | -10.02% |
| Dec 31, 2015 | 722.90M | 31.84% |
| Dec 31, 2014 | 548.30M | 39.66% |
| Dec 31, 2013 | 392.60M | 241.09% |
| Dec 31, 2012 | 115.10M | -36.16% |
| Dec 30, 2011 | 180.30M | 12.62% |
| Dec 31, 2010 | 160.10M | 73.08% |
| Dec 31, 2009 | 92.50M | 192.72% |
| Dec 31, 2008 | 31.60M | -82.95% |
| Dec 31, 2007 | 185.30M | 70.16% |
| Dec 29, 2006 | 108.90M | -15.25% |
| Dec 30, 2005 | 128.50M | -23.33% |
| Aug 5, 2005 | 167.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |